New Perspective on the Action Mechanism of Doxorubicin in Breast Cancer- Overexpressions of miR-۸۷۴-۳p and miR-۳۳۷-۳p and Downregulation of STAT۳ Gene

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 7

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JHGG-7-1_001

تاریخ نمایه سازی: 1 شهریور 1403

Abstract:

Background: Breast cancer is one of the common malignancies in women, for which doxorubicin (DOX) is widely used in its chemotherapy. Recently, it has been found that DOX affects the expression profile of oncogene genes and miRNAs. In this study, the impacts of DOX on the expressions of the STAT۳ gene, miR-۸۷۴-۳p, and miR-۳۳۷-۳p were studied in the MCF-۷ breast cancer cell line. Methods: After exposure of MCF-۷ cells with DOX, the MTT method was applied for evaluating the cell viability. Apoptosis and necrosis percentages were measured using flow cytometry. Also, the levels of ROS and NF-κB were measured in DOX-treated cells. Then, exosomes secreted from these cells were prepared. The shape of exosomes was studied by SEM. Finally, the expression of bax, bcl-۲, p۵۳, casp۳, STAT۳ gene, and miR-۸۷۴-۳p and miR-۳۳۷-۳p in MCF-۷ cells as well as exosomes were evaluated using the RT-PCR technique. Data analysis was done by T-test in GraphPad Prism۸ software. Results: The exposure of MCF-۷ cells to doxorubicin led to a concentration-dependent decrease in cell viability and increases in apoptosis and necrosis. ROS and NF-κB activity were increased in DOX-treated cells. In DOX-treated cells, decreased expressions of bcl-۲ and STAT۳ genes and overexpression of bax, p۵۳, casp۳, miR-۸۷۴-۳p, and miR-۳۳۷-۳p were observed compared to untreated control cells. Conclusion: One of the mechanisms of the anti-breast cancer effects of DOX is the induction of changes in the expression of oncogenic genes, mediating by downregulating of STAT۳ gene and overexpressing miR-۸۷۴-۳p and miR-۳۳۷-۳p. More studies are needed in this field.

Authors

Siroos Tarighi

Department of Cellular and molecular biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Maryam Montazeri

Department of Medical Biotechnology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Fatemeh Rohollah

Department of Cellular and molecular biology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Banegas MP, Bird Y, Moraros J, King S, Prapsiri S, ...
  • Shahbazi S, Alavi S, Majidzadeh-A K, GhaffarPour M, Soleimani A, ...
  • Venkitaraman AR. How do mutations affecting the breast cancer genes ...
  • Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P, Starosławska E. ...
  • Recht A, Come SE, Henderson IC, Gelman RS, Silver B, ...
  • van der Zanden SY, Qiao X, Neefjes J. New insights ...
  • Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, ...
  • Thomas SJ, Snowden JA, Zeidler MP, Danson SJ. The role ...
  • Rosmorduc O, Desbois-Mouthon C. Targeting STAT۳ in hepatocellular carcinoma: Sorafenib ...
  • Wong AL, Soo RA, Tan DS, Lee SC, Lim JS, ...
  • Chen Y, Wang J, Wang X, Liu X, Li H, ...
  • Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, ...
  • Wu G, Zhou H, Li D, Zhi Y, Liu Y, ...
  • Wang Y, Chen H, Wei X. Circ_۰۰۰۷۱۴۲ downregulates miR-۸۷۴-۳p-mediated GDPD۵ ...
  • Leong KW, Cheng CW, Wong CM, Ng IO, Kwong YL, ...
  • Luo S-D, Tsai H-T, Hwang C-F, Chiu TJ, Li SH, ...
  • Que K, Tong Y, Que G, Li L, Lin H, ...
  • Liu W-G, Zhuo L, Lu Y, Wang L, Ji Y-X, ...
  • Zhang Z, Zhang L, Wang B, Wei R, Wang Y, ...
  • Meng Q-h, Li Y, Kong C, Gao X-m, Jiang X-j. ...
  • Wang Z, Wang J, Yang Y, Hao B, Wang R, ...
  • Wang Z, Yao L, Li Y, Hao B, Wang M, ...
  • Li Q, Huang Q, Cheng S, Wu S, Sang H, ...
  • Cao X-M. Role of miR-۳۳۷-۳p and its target Rap۱A in ...
  • Eskiocak U, İşeri OD, Kars MD, Biçer A, Gunduz U. ...
  • Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L. Drug combinations ...
  • Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, ...
  • https://doi.org/۱۰.۱۰۴۲/bj۲۰۰۲۰۷۵۲Tsang W, Chau SP, Kong S, Fung K, Kwok T. ...
  • Ho WC, Dickson KM, Barker PA. Nuclear Factor-κB Induced by ...
  • Medeiros MCd, Frasnelli SCT, Bastos AdS, Orrico SRP, Rossa Junior ...
  • Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in ...
  • Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, ...
  • Rebbaa A, Chou PM, Mirkin BL. Factors secreted by human ...
  • Maryam A, Mehmood T, Zhang H, Li Y, Khan M, ...
  • Shen Q, Yao Q, Sun J, Feng L, Lu H, ...
  • Ismail IH, Andrin C, McDonald D, Hendzel MJ. BMI۱-mediated histone ...
  • Patel N, Garikapati KR, Pandita RK, Singh DK, Pandita TK, ...
  • نمایش کامل مراجع